Omnichannel has become the default model for engagement in pharma. But despite years of investment, many organisations are seeing increased complexity without a corresponding improvement in impact.

Pharma is moving quickly on AI. Tools are being deployed, pilots are underway, and investment is accelerating. But despite the activity, many organisations are struggling to convert that momentum into meaningful, scalable impact.

Pharma is investing heavily in AI and omnichannel transformation. But despite the strategy, tools, and intent, outcomes remain inconsistent. The issue isn’t ambition, it’s adoption…

How do you actually embed AI in a pharmaceutical organisation once you move beyond the excitement, the demos and the headlines?